MedPath

Amiloride Hydrochloride

AMILORIDE HYDROCHLORIDE TABLETS, USP

Approved
Approval ID

de12b6f3-3791-4d78-90e6-c487cf951738

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2023

Manufacturers
FDA

Sigmapharm Laboratories, LLC

DUNS: 556234636

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Amiloride Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42794-005
Application NumberANDA079133
Product Classification
M
Marketing Category
C73584
G
Generic Name
Amiloride Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 10, 2023
FDA Product Classification

INGREDIENTS (7)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
AMILORIDE HYDROCHLORIDE ANHYDROUSActive
Quantity: 5 mg in 1 1
Code: 7M458Q65S3
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Amiloride Hydrochloride - FDA Drug Approval Details